Determining the Relative Risk of Smoking and Physical Inactivity in Developing Osteopenia and Osteoporosis
Allied Medical Research Journal · 2023
DOI: 10.59564/amrj/01.02/007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allied Medical Research Journal, 2023. Verfasst von Farwa Abid und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Tobacco consumption is a widely recognized risk factor influencing various diseases' progression worldwide. According to the World Health Organization, tobacco consumption is responsible for 6.5 million deaths annually. Thus, the present study examined the relationship between smoking, physical inactivity, and the risk of developing osteoporosis and osteopenia. Methodology This cross-sectional study included a population-based sample of 250 participants aged 45-65. Written consent was obtained from the participants, and the study focused on assessing their smoking status. The cigarette dependency scale was utilized to measure the level of dependency on smoking.
Results
Compared to non-smokers, active smokers had a significantly higher risk (p
Zitieren
APA
Abid, F., Khalid, H., Qasim, F., Qazi, A., Asif, M. G., & Mustafa, M. (2023). Determining the Relative Risk of Smoking and Physical Inactivity in Developing Osteopenia and Osteoporosis. Allied Medical Research Journal. https://doi.org/10.59564/amrj/01.02/007
Vancouver
Abid F, Khalid H, Qasim F, Qazi A, Asif MG, Mustafa M. Determining the Relative Risk of Smoking and Physical Inactivity in Developing Osteopenia and Osteoporosis. Allied Medical Research Journal. 2023. doi:10.59564/amrj/01.02/007
BibTeX
@article{Abid2023,
author = {Abid, Farwa and Khalid, Hira and Qasim, Faria and Qazi, Ayaman and Asif, Mishal gul and Mustafa, Muhammad},
title = {Determining the Relative Risk of Smoking and Physical Inactivity in Developing Osteopenia and Osteoporosis},
journal = {Allied Medical Research Journal},
year = {2023},
doi = {10.59564/amrj/01.02/007}
}
EUVIMED